Across TCGA pan-cancer cohorts, LINC01696 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated LINC01696 data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LINC01696 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01696 expression acts as an unfavorable survival marker.
SKCM, LUSC, and PCPG are the cancer types where LINC01696 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.